Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimal Ablation Allo-SCT for CLL and Lymphoma
NCT00006252Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Feb 2001
- Primary completion
- Jan 2007
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of peripheral blood stem cells in chronic lymphocytic leukemia (CLL), prolymphocytic leukemia (PLL), non-Hodgkin lymphoma (NHL), mantle cell lymphoma (MCL), sponsored by Cancer and Leukemia Group B. Started Feb 2001; status: completed.
02
Drugs
peripheral blood stem cells
03
Conditions
chronic lymphocytic leukemia (CLL)prolymphocytic leukemia (PLL)non-Hodgkin lymphoma (NHL)mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00006252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006252.